Peter Rossing

Peter Rossing

Clinical Professor

Member of:

  • Internal Medicine: Endocrinology


  1. Published

    Can the Use of Continuous Glucose Monitoring Improve Glycemic Control in Patients with Type 1 and 2 Diabetes Receiving Dialysis?

    Bomholt, T., Kofod, D., Nørgaard, Kirsten, Rossing, Peter, Feldt-Rasmussen, Bo & Hornum, Mads, 2023, In: Nephron. 147, 2, p. 91-96 6 p.

    Research output: Contribution to journalReviewResearchpeer-review

  2. Published

    Reduction of cardiac adipose tissue volume with short-term empagliflozin treatment in patients with type 2 diabetes: A substudy from the SIMPLE randomized clinical trial

    Brandt-Jacobsen, N. H., Jurgens, M., Hasbak, P., Gaede, P., Rossing, Peter, Rasmussen, J. J., Andersen, C. F., Forman, Julie Lyng, Faber, Jens, Inzucchi, S. E., Gustafsson, Finn, Schou, Morten & Kistorp, Caroline Michaela Nervil, 2023, In: Diabetes, Obesity and Metabolism. 25, 3, p. 844-855 12 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Effects of Dapagliflozin in Chronic Kidney Disease, With and Without Other Cardiovascular Medications: DAPA-CKD Trial

    Chertow, G. M., Correa-Rotter, R., Vart, P., Jongs, N., McMurray, J. J. V., Rossing, Peter, Langkilde, A. M., Sjöström, C. D., Toto, R. D., Wheeler, D. C., Heerspink, H. J. L. & Dapa-Ckd Trial Committees Investigators, D. T. C. I., 2023, In: Journal of the American Heart Association. 12, 9, 22 p., e028739.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Optimization of Albuminuria-Lowering Treatment in Diabetes by Crossover Rotation to Four Different Drug Classes: A Randomized Crossover Trial

    Curovic, V. R., Jongs, N., Kroonen, M. Y. A. M., Zobel, E. H., Hansen, T. W., Sen, T., Laverman, G. D., Kooy, A., Persson, F., Rossing, Peter & Heerspink, H. J. L., 2023, In: Diabetes Care. 46, 3, p. 593-601 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Finerenone efficacy in patients with chronic kidney disease, type 2 diabetes and atherosclerotic cardiovascular disease

    Filippatos, G., Anker, S. D., Pitt, B., McGuire, D. K., Rossing, Peter, Ruilope, L. M., Butler, J., Jankowska, E. A., Michos, E. D., Farmakis, D., Farjat, A. E., Kolkhof, P., Scalise, A., Joseph, A., Bakris, G. L. & Agarwal, R., 2023, In: European heart journal. Cardiovascular pharmacotherapy. 9, 1, p. 85-93 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Finerenone and effects on mortality in chronic kidney disease and type 2 diabetes: a FIDELITY analysis

    Filippatos, G., Anker, S. D., August, P., Coats, A. J. S., Januzzi, J. L., Mankovsky, B., Rossing, Peter, Ruilope, L. M., Pitt, B., Sarafidis, P., Teerlink, J. R., Kapelios, C. J., Gebel, M., Brinker, M., Joseph, A., Lage, A., Bakris, G. & Agarwal, R., 2023, In: European heart journal. Cardiovascular pharmacotherapy. 9, 2, p. 183-191 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    Finerenone in Black Patients With Type 2 Diabetes and CKD: A Post hoc Analysis of the Pooled FIDELIO-DKD and FIGARO-DKD Trials

    Flack, J. M., Agarwal, R., Anker, S. D., Pitt, B., Ruilope, L. M., Rossing, Peter, Adler, S. G., Fried, L., Jamerson, K., Toto, R., Brinker, M., Farjat, A. E., Kolkhof, P., Lawatscheck, R., Joseph, A., Bakris, G. L. & FIDELIO-DKD and FIGARO-DKD Investigators, F. A. F. I., 2023, In: Kidney Medicine. 5, 12, 11 p., 100730.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    Effect of SGLT2 Inhibitors on Discontinuation of Renin–angiotensin System Blockade: A Joint Analysis of the CREDENCE and DAPA-CKD Trials

    Fletcher, R. A., Jongs, N., Chertow, G. M., McMurray, J. J. V., Arnott, C., Jardine, M. J., Mahaffey, K. W., Perkovic, V., Rockenschaub, P., Rossing, Peter, Correa-Rotter, R., Toto, R. D., Vaduganathan, M., Wheeler, D. C., Heerspink, H. J. L. & Neuen, B. L., 2023, In: Journal of the American Society of Nephrology. 34, 12, p. 1965-1975 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    Design of the COmbinatioN effect of FInerenone anD EmpaglifloziN in participants with chronic kidney disease and type 2 diabetes using a UACR Endpoint study (CONFIDENCE)

    Green, J. B., Mottl, A. K., Bakris, G., Heerspink, H. J. L., Mann, J. F. E., Mcgill, J. B., Nangaku, M., Rossing, Peter, Scott, C., Gay, A. & Agarwal, R., 2023, In: Nephrology Dialysis Transplantation. 38, 4, p. 894-903 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    Collagen turnover is associated with cardiovascular autonomic and peripheral neuropathy in type 1 diabetes: novel pathophysiological mechanism?

    Hansen, C. S., Rasmussen, D. G. K., Hansen, T. W., Nielsen, S. H., Theilade, S., Karsdal, M. A., Genovese, F. & Rossing, Peter, 2023, In: Cardiovascular Diabetology. 22, 1, 11 p., 158.

    Research output: Contribution to journalJournal articleResearchpeer-review

ID: 12937790